Dynavax Technologies (DVAX)

Apr 22, 2025, 4:00 PM EDT - 1 day ago

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Apr 21, 2025, 4:05 PM EDT - 2 days ago

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Apr 17, 2025, 7:15 AM EDT - 6 days ago

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

Apr 16, 2025, 8:00 AM EDT - 7 days ago

Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer

Apr 3, 2025, 5:40 PM EDT - 20 days ago

Dynavax Files Preliminary Proxy Statement

Mar 10, 2025, 8:00 AM EDT - 6 weeks ago

Deep Track Capital Sends Letter to Dynavax Technologies' Board of Directors

Mar 6, 2025, 6:00 AM EST - 6 weeks ago

Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase

Mar 3, 2025, 5:58 PM EST - 7 weeks ago

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share

Feb 25, 2025, 4:10 PM EST - 2 months ago

Dynavax to Participate in Upcoming Investor Conferences

Feb 20, 2025, 6:38 PM EST - 2 months ago

Dynavax Technologies Corporation (DVAX) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 4:01 PM EST - 2 months ago

Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance

Feb 19, 2025, 4:52 PM EST - 2 months ago

Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy

Feb 19, 2025, 9:00 AM EST - 2 months ago

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies' Board of Directors at 2025 Annual Meeting

Feb 19, 2025, 8:04 AM EST - 2 months ago

Exclusive: Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors

Feb 11, 2025, 3:11 PM EST - 2 months ago

Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty

Feb 6, 2025, 5:42 PM EST - 2 months ago

Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025

Jan 27, 2025, 6:00 AM EST - 3 months ago

Dynavax Advances Board Refreshment Program

Jan 13, 2025, 9:00 AM EST - 3 months ago

Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

Nov 26, 2024, 4:05 PM EST - 5 months ago

Dynavax to Present at the 7th Annual Evercore HealthCONx Conference

Nov 13, 2024, 6:36 PM EST - 5 months ago

Dynavax Technologies: What The Stock Buyback Means.  What It Doesn't

Nov 11, 2024, 8:00 AM EST - 5 months ago

Dynavax Announces $100 Million Accelerated Share Repurchase Program

Nov 7, 2024, 7:46 PM EST - 5 months ago

Dynavax Technologies Corporation (DVAX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:02 PM EST - 5 months ago

Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates

Nov 7, 2024, 4:01 PM EST - 5 months ago

Dynavax Announces $200 Million Share Repurchase Program

Nov 6, 2024, 1:10 PM EST - 6 months ago

Glancy Prongay & Murray LLP Announces Investigation of Dynavax Technologies Corporation (DVAX)

Oct 29, 2024, 8:30 AM EDT - 6 months ago

Dynavax Adopts Limited-Duration Stockholder Rights Plan

Oct 24, 2024, 4:10 PM EDT - 6 months ago

Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024

Sep 25, 2024, 12:46 PM EDT - 7 months ago

3 'Repeatable' Biotech Trades

FOLD GSK NTLA XBI

Aug 23, 2024, 4:32 AM EDT - 8 months ago

Dynavax Technologies: A Two Trick Pony Operating With A Single Trick

Aug 6, 2024, 8:54 PM EDT - 9 months ago

Dynavax Technologies Corporation (DVAX) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 4:01 PM EDT - 9 months ago

Dynavax Reports Second Quarter 2024 Financial Results and Provides Business Updates

Jul 23, 2024, 4:00 PM EDT - 9 months ago

Dynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024

Jun 27, 2024, 4:09 PM EDT - 10 months ago

Dynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program

May 28, 2024, 4:18 PM EDT - 11 months ago

Dynavax to Present at Upcoming Investor Conferences

May 14, 2024, 8:39 AM EDT - 1 year ago

US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine

May 14, 2024, 8:30 AM EDT - 1 year ago

Dynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B® Regimen for Adults on Hemodialysis in the U.S.

May 8, 2024, 7:51 PM EDT - 1 year ago

Dynavax Technologies Corporation (DVAX) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:01 PM EDT - 1 year ago

Dynavax Reports First Quarter 2024 Financial Results and Provides Business Updates

Apr 24, 2024, 4:05 PM EDT - 1 year ago

Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

Mar 24, 2024, 7:39 AM EDT - 1 year ago

Dynavax Technologies: Still A Believer

Feb 27, 2024, 6:54 PM EST - 1 year ago

Dynavax to Present at TD Cowen's 44th Annual Health Care Conference

Feb 22, 2024, 7:34 PM EST - 1 year ago

Dynavax Technologies Corporation (DVAX) Q4 2023 Earnings Call Transcript

Feb 22, 2024, 4:01 PM EST - 1 year ago

Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance

Feb 8, 2024, 4:15 PM EST - 1 year ago

Dynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024

Jan 8, 2024, 9:00 AM EST - 1 year ago

Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights

Jan 3, 2024, 6:33 PM EST - 1 year ago

Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Jan 2, 2024, 1:53 PM EST - 1 year ago

Dynavax Technologies: Still A Solid Pick For 2024

Dec 26, 2023, 12:18 PM EST - 1 year ago

20 favorite small-cap stocks for 2024 among Wall Street analysts

ARLO CPRX DGII GPRE HLX IRWD LGND

Nov 20, 2023, 5:04 PM EST - 1 year ago

Dynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference

Nov 2, 2023, 7:07 PM EDT - 1 year ago

Dynavax Technologies Corporation (DVAX) Q3 2023 Earnings Call Transcript